SVSandra Verelst

Sandra Verelst

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sandra Verelst has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Prediction Model to Identify Clinically Relevant Medication Discrepancies at the Emergency Department (MED-REC Predictor): Development and Validation Study

    by Greet Van De Sijpe, Matthias Gijsen, Lorenz Van der Linden, Stephanie Strouven, Eline Simons, Emily Martens, Nele Persan, Veerle Grootaert, Veerle Foulon, Minne Casteels, et al.

    Background: Many patients do not receive a comprehensive medication reconciliation, mostly owing to limited resources. We hence need an approach to identify those patients at the emergency department (ED) who are at increased risk for clinically relevant discrepancies. Objective: The aim of our study was to develop and externally validate a prediction model to identify patients at risk for at least 1 clinically relevant medication discrepancy upon ED presentation. Methods: A prospective, multicenter, observational study was conducted at the University Hospitals Leuven and General Hospital Sint-Jan Brugge-Oostende AV, Belgium. Medication histories were obtained from patients admitted to the ED between November 2017 and May 2022, and clinically relevant medication discrepancies were identified. Three distinct datasets were created for model development, temporal external validation, and geographic external validation. Multivariable logistic regression with backward stepwise selection was used to select the final model. The presence of at least 1 clinically relevant discrepancy was the dependent variable. The model was evaluated by measuring calibration, discrimination, classification, and net benefit. Results: We included 824, 350, and 119 patients in the development, temporal validation, and geographic validation dataset, respectively. The final model contained 8 predictors, for example, age, residence before admission, number of drugs, and number of drugs of certain drug classes based on Anatomical Therapeutic Chemical coding. Temporal validation showed excellent calibration with a slope of 1.09 and an intercept of 0.18. Discrimination was moderate with a c-index (concordance index) of 0.67 (95% CI 0.61-0.73). In the geographic validation dataset, the calibration slope and intercept were 1.35 and 0.83, respectively, and the c-index was 0.68 (95% CI 0.58-0.78). The model showed net benefit over a range of clinically reasonable threshold probabilities and outperformed other selection criteria. Conclusions: Our software-implemented prediction model shows moderate performance, outperforming random or typical selection criteria for medication reconciliation. Depending on available resources, the probability threshold can be customized to increase either the specificity or the sensitivity of the model.


  • Open Access

    A Prediction Model to Identify Clinically Relevant Medication Discrepancies at the Emergency Department (MED-REC Predictor): Development and Validation Study (Preprint)

    by Greet Van De Sijpe, Matthias Gijsen, Lorenz Van der Linden, Stephanie Strouven, Eline Simons, Emily Martens, Nele Persan, Veerle Grootaert, Veerle Foulon, Minne Casteels, et al.

    BACKGROUND Many patients do not receive a comprehensive medication reconciliation, mostly owing to limited resources. We hence need an approach to identify those patients at the emergency department (ED) who are at increased risk for clinically relevant discrepancies. OBJECTIVE The aim of our study was to develop and externally validate a prediction model to identify patients at risk for at least 1 clinically relevant medication discrepancy upon ED presentation. METHODS A prospective, multicenter, observational study was conducted at the University Hospitals Leuven and General Hospital Sint-Jan Brugge-Oostende AV, Belgium. Medication histories were obtained from patients admitted to the ED between November 2017 and May 2022, and clinically relevant medication discrepancies were identified. Three distinct datasets were created for model development, temporal external validation, and geographic external validation. Multivariable logistic regression with backward stepwise selection was used to select the final model. The presence of at least 1 clinically relevant discrepancy was the dependent variable. The model was evaluated by measuring calibration, discrimination, classification, and net benefit. RESULTS We included 824, 350, and 119 patients in the development, temporal validation, and geographic validation dataset, respectively. The final model contained 8 predictors, for example, age, residence before admission, number of drugs, and number of drugs of certain drug classes based on Anatomical Therapeutic Chemical coding. Temporal validation showed excellent calibration with a slope of 1.09 and an intercept of 0.18. Discrimination was moderate with a c-index (concordance index) of 0.67 (95% CI 0.61-0.73). In the geographic validation dataset, the calibration slope and intercept were 1.35 and 0.83, respectively, and the c-index was 0.68 (95% CI 0.58-0.78). The model showed net benefit over a range of clinically reasonable threshold probabilities and outperformed other selection criteria. CONCLUSIONS Our software-implemented prediction model shows moderate performance, outperforming random or typical selection criteria for medication reconciliation. Depending on available resources, the probability threshold can be customized to increase either the specificity or the sensitivity of the model.

  • Open Access

    4CPS-114 Development and prospective validation of a prediction model to identify clinically relevant medication discrepancies at the emergency department

    by G Van De Sijpe, M Gijsen, L Van Der Linden, S Strouven, V Foulon, M Casteels, S Verelst, P Vanbrabant, S De Winter, I Spriet

    Background and Importance Medication discrepancies occur in a majority of hospital admissions to the emergency department (ED) and are a major source of avoidable harm. Obtaining an accurate medication history is essential to identify drug-related problems early on. However, the medication reconciliation process is prone to many errors and is furthermore labour-intensive. As a result, many patients simply do not receive a complete medication reconciliation, mostly owing to limited recourses. We hence need an approach which enables us to identify those patients at the ED who are at increased risk for clinically relevant discrepancies. Aim and Objectives To develop and prospectively validate a prediction model to identify patients who are at risk for at least one clinically relevant medication discrepancy at the time of ED presentation. Material and Methods A prospective study was carried out at the ED. Medication histories were obtained and clinically relevant discrepancies were identified, using an internally validated scoring tool. Two distinct datasets were created. A first dataset (n=824) was used to build and internally validate a prediction model. We used multivariable logistic regression with backward stepwise selection to select the final model. A second dataset (n= 350) was used to prospectively validate the prediction model. The predictive performance of this model was assessed by measuring calibration, discrimination and classification. Results The final model contained nine predictors that can easily be obtained upon ED admission, including age, origin before admission (home/nursing home) and number of drugs. Prospective validation showed excellent calibration with a slope of 1.09 and an intercept of 0.18. Discrimination was moderate with a c-index of 0.66. Using a probability threshold of 0.4, the sensitivity, specificity, positive predictive value, negative predictive value and alert rate was 41%, 81%, 56%, 70% and 27%, respectively. Conclusion and Relevance The presence of at least one clinically relevant medication discrepancy can be predicted by our model with moderate performance. Using our prediction model is more efficient than performing medication reconciliation at random and can guide the rational use of limited resources at the ED. Depending on the available resources, different probability thresholds can be applied to increase either the specificity or the sensitivity of the prediction model. Conflict of Interest No conflict of interest

  • The 12 -year evolution of emergency department alcohol-related admissions in a student city

    by Steffi Panken, Lina Wauters, Roos Gijbels, Hilde Quintens, Assen A. Abouem Dorette, Sandra Verelst

    To investigate the trends in incidence of alcohol-intoxicated patients who present at the emergency department (ED), as well as the characteristics of these patients.Retrospective observational stu...


  • Assessment of chest compression interruptions during advanced cardiac life support

    by Philippe Dewolf, Lina Wauters, Geraldine Clarebout, Senne Van Den Bempt, Thomas Uten, Didier Desruelles, Sandra Verelst


  • Impact of video-recording on patient outcome and data collection in out-of-hospital cardiac arrests

    by Philippe Dewolf, Boyd Rutten, Lina Wauters, Senne Van Den Bempt, Thomas Uten, Joke Van Kerkhoven, Didier Desruelles, Geraldine Clarebout, Sandra Verelst


  • Predicting patient nurse-level intensity for a subsequent shift in the intensive care unit: A single-centre prospective observational study

    by Karen Decock, Michael P. Casaer, Fabian Guïza, Pieter Wouters, Mieke Florquin, Alexander Wilmer, Stefan Janssens, Sandra Verelst, Greet Van Den Berghe, Luk Bruyneel


  • Open Access

    Developing an emergency department crowding dashboard: A design science approach

    by Niels Martin, Jochen Bergs, Dorien Eerdekens, Benoît Depaire, Sandra Verelst


  • Open Access

    Emergency Department Visits Due to Alcohol Intoxication: Characteristics of Patients and Impact on the Emergency Room

    by Sandra Verelst, Pieter-Jan Moonen, Didier Desruelles, Jean-Bernard Gillet

    Aims: The aim of the study was to describe the epidemiology, management and cost of emergency department (ED) visits due to alcohol intoxication. Methods: A retrospective review of medical records of all episodes of alcohol intoxication was made, excepting those where another diagnosis such as trauma or psychiatric illness was primary, in patients older than 16 years, who presented to the ED of a large university hospital in Belgium over a 12-month period from 1 January 2009. Results: A total of 635 such patients accounted for 1.2% of all ED visits; 429 were males and 48.3% were aged between 41 and 60 years; 63.8% of the patients had a history of alcohol use disorder and 60.3% had a history of psychiatric disorder; 74.3% of the patients received some form of medical treatment and 62% were seen by a psychiatrist. Of the total, 57.5% of the patients were admitted to the ED observation ward, with a mean length of stay of 8.4 h. The estimated total cost was €318 838.25, with an average of €541.32 per patient. Conclusion: Alcohol intoxication leads to a financial burden on the community. In addition to imposing physical, social and psychological stress on the community, the often agitated or aggressive patient imposes stress on ED staff. Close surveillance of trends in alcohol abuse is warranted, and the ED should consider implementing a questionnaire method of screening for alcohol abuse.


  • Ethylene glycol poisoning presenting with a falsely elevated lactate level

    by Sandra Verelst, Pieter Vermeersch, Koen Desmet

    Early diagnosis of ethylene glycol poisoning is crucial in order to prevent morbidity and mortality. However, diagnosis can sometimes be delayed because of the false elevation of lactate in some chemistry analyzers as a result of the interference of glycolate, a metabolite of ethylene glycol. We present a case of ethylene glycol poisoning presenting with a falsely elevated lactate level on a blood gas analyzer in the emergency department. Given the fact that nowadays there is a marked increase in use of point-of-care analyzers, one should be aware of possible false readings since they use different methods of measuring compared with clinical chemistry analyzers. On the other hand, measuring a “lactate gap” using two different technologies, only one of which is sensitive to glycolate, could be a clinically efficient way to make the diagnosis of advanced ethylene glycol poisoning in the emergency department or other critical care setting.